Funding, News and Announcements
» Go to news mainPfizer Quality Improvement RFP
This competitive grant program seeks to support quality improvement projects focused on improving the identification and management of ATTR-CM patients.
Projects that will be considered for Pfizer support will focus on improving the identification and management of ATTR-CM patients by providing leadership, best practices, novel clinical pathways, support and/or training of HCPs within a multidisciplinary team environment to improve the quality of care for patients with ATTR-CM. Â
Particular consideration will be given to projects intended to improving care, and / or access to care for underrepresented populations (women, individuals of African-American Descent, First Nations, Métis and Inuit or other underrepresented communities)
.
Deadlines
Internal: March 31, 2023 at 4:30pm. Contact email is ird@dal.ca. For additional resources, click here for guidance on internal deadlines and submission processes.
Funder: April 17, 2023. Contact email is amanda.j.stein@pfizer.com.
Recent News
- Global Cardiovascular Research Funders Form (GCRFF) International Research Challenge on Women’s Cardiovascular Health
- Faculty Mobility for Partnership Building Program (FMPBP) 2025‑26
- Horizon Europe and Canada Online Matchmaking Event
- SSHRC
- GlycoNet Funding Competitions for Research Projects
- MINDS Defence and Security Research Funding
- NSERC Contact Newsletter
- Digital Research Alliance of Canada